49.41.Z - Road freight transport
21.20.Z - Manufacture of pharmaceutical preparations and other pharmaceutical products
47.73.Z - Retail sale of pharmaceutical products
47.75.Z - Retail sale of cosmetics and toiletries
47.91.Z - Intermediary retail sale, non-specialized
47.99.Z - Retail trade
68.20.Z - Rental and management of own or leased real estate
45.11.Z
45.19.Z
45.40.Z
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss) | 0,6 | 0,8 | 0,7 | -2,5 |
EBITDA | 0,7 | 0,9 | 1 | 10,5 |
Short time liabilities | 1,3 | 1,7 | 1,5 | -10,2 |
Equity capital | 4,4 | 5 | 5,4 | 7,7 |
Operating profit (EBIT) | 0,6 | 0,8 | 0,9 | 11 |
Assets | 5,7 | 6,8 | 7 | 3,1 |
Net profit (loss) | 0,5 | 0,7 | 0,6 | -3,7 |
Cash | 2,5 | 3 | 3,6 | 17 |
Net income from sale | 6,2 | 7,6 | 7,2 | -5,9 |
Liabilities and provisions for liabilities | 1,4 | 1,7 | 1,6 | -10,3 |
Working assets | 4,1 | 5,3 | 5,3 | 1,3 |
Depreciation | 0,1 | 0,2 | 0,2 | 8,3 |
% | % | % | p.p. | |
Profitability of capital | 11,5 | 13,2 | 11,8 | -1,4 |
Equity capital to total assets | 76,3 | 74,5 | 77,8 | 3,3 |
Gross profit margin | 9,2 | 9,8 | 10,2 | 0,4 |
EBITDA Margin | 11,4 | 12,1 | 14,2 | 2,1 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 79 | 81 | 77 | -4 |
Current financial liquidity indicator | 3.0434205532073975 | 3.04132080078125 | 3.433821201324463 | 0,4 |
Net dept to EBITDA | -3.1968021392822266 | -3.0027787685394287 | -3.402398109436035 | -0,4 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane